Two highly relevant, recent @Nature papers have been published to deepen our understanding of the potential benefit of imatinib for the treatment of #Covid_19:

Team at University of Maryland, Baltimore recently published their protocol for study of oral imatinib in hospitalized adults with COVID-19

Really pleased to announce that the CounterCOVID study has today achieved 50% inclusion
#Clinicaltrial #COVID19

Load More...